NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 973 coverCELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS Copyright © 2002 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by PORCILE, C.
Articles by SCHETTINIA, G.
Search for Related Content
PubMed
PubMed Citation
Articles by PORCILE, C.
Articles by SCHETTINIA, G.
Annals of the New York Academy of Sciences 973:402-413 (2002)
© 2002 New York Academy of Sciences

Proteasome Inhibitors Induce Cerebellar Granule Cell Death

Inhibition of Nuclear Factor-kB Activation

CAROLA PORCILEa,b, PATRIZIA PICCIOLIa,b, SABRINA STANZIONEa, ADRIANA BAJETTOa,c, RUDY BONAVIAa,c, SIMONE BARBEROa,c, TULLIO FLORIOa,d AND GENNARO SCHETTINIAc

aSection of Pharmacology and Neuroscience, National Institute for Cancer Research (IST), c/o CBA Largo Rosanna Benzi 10, 16132 Genova, Italy
cSection of Pharmacology, Department of Oncology, Biology and Genetics, School of Medicine, University of Genova, Genova, Italy
dDepartment of Biomedical Sciences, School of Medicine, University of Chieti, Chieti, Italy

Address for correspondence: Gennaro Schettini, Section of Pharmacology and Neuroscience, National Institute for Cancer Research, c/o CBA Largo Rosanna Benzi 10, 16132 Genova, Italy. Voice: 0039-10-5737256; fax 0039-10-5737257.
schettini{at}sirio.cba.unige.it
bThese authors contributed equally to this work.
Ann. N.Y. Acad. Sci. 973: 402-413 (2002).

Many activities of neuronal cells, such as synaptic transmission, inflammation, neuroprotection, and neurotoxicity, are regulated by the activity of the transcription factor nuclear factor-{kappa}B (NF-{kappa}B). In resting cells, NF-{kappa}B activity is present both in the cytoplasm, as an inducible-inactive complex, and in the nucleus as a constitutive form. The activation of its inducible form is related to processing of I{kappa}B(s), which occurs through the proteasome. To understand whether NF-{kappa}B is involved in the survival of cerebellar granule cells (CGCs) maintained under conditions of mild depolarization (25 mM KCl), these cells were treated with different proteasome inhibitors. The results presented show that these pharmacological tools reduce CGC survival with changes in nuclear morphology and induction of apoptosis. Furthermore, we demonstrate that PSI-induced apoptosis is reverted by inhibitors of transcription and translation, as well as by specific caspase inhibitors. These issues are also associated with a redistribution of NF-{kappa}B, in that a reduced amount of nuclear NF-{kappa}B and an increased p65 cytoplasmic level have been observed. Finally, we propose that, at least in part, p65 metabolism could also be regulated by the ubiquitin-proteasome complex. Altogether, the results presented define an important role for NF-{kappa}B in maintainig CGC survival.

Key Words: apoptosis • cerebellar granule cells • nuclear factor-kB • p65 • ubiquitin-proteasome complex




This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Wu and F. De Luca
Inhibition of the Proteasomal Function in Chondrocytes Down-Regulates Growth Plate Chondrogenesis and Longitudinal Bone Growth
Endocrinology, August 1, 2006; 147(8): 3761 - 3768.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Fioriti, S. Dossena, L. R. Stewart, R. S. Stewart, D. A. Harris, G. Forloni, and R. Chiesa
Cytosolic Prion Protein (PrP) Is Not Toxic in N2a Cells and Primary Neurons Expressing Pathogenic PrP Mutations
J. Biol. Chem., March 25, 2005; 280(12): 11320 - 11328.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Drisaldi, R. S. Stewart, C. Adles, L. R. Stewart, E. Quaglio, E. Biasini, L. Fioriti, R. Chiesa, and D. A. Harris
Mutant PrP Is Delayed in Its Exit from the Endoplasmic Reticulum, but Neither Wild-type nor Mutant PrP Undergoes Retrotranslocation Prior to Proteasomal Degradation
J. Biol. Chem., June 6, 2003; 278(24): 21732 - 21743.
[Abstract] [Full Text] [PDF]



footerLeft footerRight